# Trade Mark Journal No.2026/022 29 May 2026

## WO0000001917124 (5)

Office of origin: Republic of Korea

Date of International Registration:10 April 2026
Date of designation in the UK: 10 April 2026

International priority date claimed: 13 January 2026 (Republic of Korea) (4020260007539)

Class 5
  Pharmaceutical preparations for human use; antibodies for medical purposes; pharmaceutical preparations for the treatment of multiple sclerosis; pharmaceutical preparations for the treatment of autoimmune disorders; pharmaceutical preparations for the treatment of central nervous system diseases; pharmaceutical preparations for the treatment of inflammatory diseases.

CELLTRION, INC.

Representative: JIDAM IP LAW FIRM, A-201, U Space 2, 670, Deawangpangyo-ro,, Bundang-gu, Seongnam-si, Gyeonggi-do, REPUBLIC OF KOREA